Drugs / Aminoflavone Prodrug
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01015521 | Apr 2010 → Dec 2012 | breast neoplasm | Tigris Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aminoflavone Prodrug | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01015521 ↗ |